Cuba vs Liberia: Antiretroviral therapy coverage for PMTCT
Cuba
89.0%
in 2024
Liberia
88.0%
in 2024
Cuba rank
30th
Liberia rank
31st
Antiretroviral therapy coverage for PMTCT over time
- Cuba
- Liberia
How they compare
Cuba currently reports 89.0% against 88.0% in Liberia, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Liberia ahead.
Cuba ranks 30th and Liberia ranks 31st of 84 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.4% | 2.3% | 34.1% | Cuba |
| 2010s | 73.9% | 40.8% | 33.1% | Cuba |
| 2020s | 97.6% | 72.8% | 24.8% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cuba or Liberia?
- Cuba, at 89.0% against 88.0% in Liberia as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cuba and Liberia?
- 1.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Liberia?
- 25 years are reported by both, from 2000 to 2024.
- How do Cuba and Liberia rank globally for antiretroviral therapy coverage for pmtct?
- Cuba ranks 30th and Liberia ranks 31st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).